Sunshine Act Meeting, 4612 [06-866]
Download as PDF
<![CDATA[
4612
Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices
investigation on the basis of two
settlement agreements.
rmajette on PROD1PC67 with NOTICES
FOR FURTHER INFORMATION CONTACT:
Steven Crabb, Esq., Office of the General
Counsel, U.S. International Trade
Commission, 500 E Street, SW.,
Washington, DC 20436, telephone (202)
708–5432. Copies of non-confidential
documents filed in connection with this
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street, SW., Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
Internet server (https://www.usitc.gov).
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: This
investigation was instituted by the
Commission based on a complaint filed
by BenQ Corporation of Taiwan and
BenQ America Corporation of Irvine,
California. See 70 FR 35453 (June 20,
2005). The complaint alleged violations
of section 337 of the Tariff Act of 1930
in the importation into the United
States, the sale for importation, and the
sale in the United States after
importation of certain DVD/CD players
and recorders, color television receivers
and monitors, and components thereof
by reason of infringement of claims 7–
11 and 13–15 of U.S. Patent No.
5,270,821, and claims 1, 2, 4, and 5 of
U.S. Patent No. 6,683,842. The
complaint named Thomson Inc. of
Indianapolis, Indiana as the respondent.
On December 9, 2005, the private
parties filed a joint motion to terminate
the investigation on the basis of two
settlement agreements. On December 14,
2005, the Commission investigative
attorney filed a response in support of
the parties’ joint motion to terminate the
investigation.
On December 21, 2005, the ALJ issued
an ID (Order No. 16) granting the joint
motion to terminate the investigation on
the basis of the settlement agreements.
The ALJ found no indication that such
termination of the investigation would
adversely impact the public interest. No
party filed a petition to review the
subject ID.
The Commission has determined not
to review the ALJ’s ID. Accordingly, the
above-referenced investigation is hereby
terminated.
VerDate Aug<31>2005
15:17 Jan 26, 2006
Jkt 208001
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in
sections 210.21(b), and 210.42 of the
Commission’s Rules of Practice and
Procedure (19 CFR 210.21, 210.42).
By order of the Commission.
Issued: January 23, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E6–1038 Filed 1–26–06; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on August
17, 2005, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock,
Texas 78664, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in Schedule
I and II:
Drug
Schedule
[USITC SE–06–009]
Sunshine Act Meeting
United
States International Trade Commission.
TIME AND DATE: February 8, 2006 at 11
a.m.
PLACE: Room 101, 500 E Street, SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agenda for future meetings: none.
2. Minutes.
3. Ratification List.
4. Inv. No. 731–TA–1089 (Final)(Certain
Orange Juice from Brazil)—briefing
and vote. (The Commission is
currently scheduled to transmit its
determination and Commissioners’
opinions to the Secretary of
Commerce on or before February 21,
2006.)
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
Issued: January 25, 2006.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 06–866 Filed 1–25–06; 3:48 pm]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
Gamma
hydroxybutyric
acid
(2010).
Ibogaine (7260) ............................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4Methylenedioxymethamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Etorphine (9056) ...........................
Heroin (9200) ...............................
Pholcodine (9314) ........................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import small
quantities of the listed controlled
E:\FR\FM\27JAN1.SGM
27JAN1
]]>Agencies
[Federal Register Volume 71, Number 18 (Friday, January 27, 2006)]
[Notices]
[Page 4612]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-866]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[USITC SE-06-009]
Sunshine Act Meeting
Agency Holding the Meeting: United States International Trade
Commission.
Time and Date: February 8, 2006 at 11 a.m.
Place: Room 101, 500 E Street, SW., Washington, DC 20436, Telephone:
(202) 205-2000.
Status: Open to the public.
Matters To Be Considered:
1. Agenda for future meetings: none.
2. Minutes.
3. Ratification List.
4. Inv. No. 731-TA-1089 (Final)(Certain Orange Juice from Brazil)--
briefing and vote. (The Commission is currently scheduled to transmit
its determination and Commissioners' opinions to the Secretary of
Commerce on or before February 21, 2006.)
5. Outstanding action jackets: None.
In accordance with Commission policy, subject matter listed above,
not disposed of at the scheduled meeting, may be carried over to the
agenda of the following meeting.
Issued: January 25, 2006.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 06-866 Filed 1-25-06; 3:48 pm]
BILLING CODE 7020-02-P
